Ex vivo expanded Tumour Infiltrating Lymphocytes (TILs) from ovarian cancer patients release anti-tumour cytokines in response to autologous primary ovarian cancer cells
Research output: Contribution to journal › Article › peer-review
Fingerprint
Dive into the research topics of 'Ex vivo expanded Tumour Infiltrating Lymphocytes (TILs) from ovarian cancer patients release anti-tumour cytokines in response to autologous primary ovarian cancer cells'. Together they form a unique fingerprint.